Godavari Drugs Ltd
₹123.60▼ -9.80 (-7.35%)
GODAVARI·BSE·FMCG
Market Cap
124.11 Cr
PE Ratio
16.55
Volume
14,197
Day High - Low
128.05 - 119.45
52W High-Low
144.35 - 69.70
₹123.60▼ -9.80 (-7.35%)
Market Cap124.11 Cr
PE Ratio16.55
Volume14,197
Day High - Low128.05 - 119.45
52W High-Low144.35 - 69.70
Godavari Drugs Ltd (GODAVARI): company summary
The company's annual revenue fell 6.7% to ₹106 crore, while annual net profit remained flat at ₹4 crore.
Godavari Drugs Ltd (GODAVARI) is a micro-cap FMCG company valued at ₹124 crore operating in Diversified FMCG on the NSE and BSE.
- Recent price move
- Godavari Drugs Ltd last traded at ₹123.6, sharply down 7.35% on the day.
- Financial performance
- The company's annual revenue fell 6.7% to ₹106 crore, while annual net profit remained flat at ₹4 crore. The latest quarter saw revenue rise 17.4% year-on-year to ₹28 crore, and net profit grew 6.7% to ₹1 crore, showing some improvement in recent performance.
- Valuation multiples
- The stock trades at 16.6 times earnings, 1.39 times book value.
- Things to watch
- The company's revenue has declined over the past three years, with a compound annual growth rate of -12.9%. Net profit has grown very slowly, with a 0.7% annual growth rate over three years. The stock is 7.6% below its 52-week high, and the company's market cap is ₹135 crore, indicating a micro-cap position.
- Where it stands
- Godavari Drugs Ltd has seen a decline in revenue over the past three years, with only modest growth in net profit. The latest quarter showed a positive trend with revenue and net profit both rising year-on-year. The stock is currently trading at 7.6% below its 52-week high, and the company's market cap remains small at ₹135 crore.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.7/10
Weak
Fair Value
Sign in to see
ROE
5.39%
Weak
P/E
16.55x
Fair
Debt / Equity
1.01
Elevated
Industry
FMCG
Diversified FMCG
Overall View
Mixed
Price performance
Day₹119.45
₹128.05
52W₹69.70
₹144.35
DocStoX take
Supported by risk (7.5) and momentum (7.5), but held back by growth (2.0). Risk looks strong at 7.5, but that is offset by growth at 2.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence4.7
/10
Weak
Quality
Modest
ROE 5.4%
Valuation
Rich
P/E 16.6×
Growth
Flat
Revenue -3.0% 5Y CAGR
Risk
Low risk
D/E 1.01
Momentum
Strong
72% of 52-week range
At a glance
Market Cap
₹124 Cr
52W High / Low
₹144 / ₹70
Dividend Yield
0.00%
Promoter Holding
40.23%
EPS (TTM)
₹7.47
Book Value
₹74.85
Key highlights
- Profitable in all of the last 5 years
- Revenue shrinking 3% a year
- Growth is weak (2.0/10)
1 Positive3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More FMCG stocks · Diversified FMCG
Explore Godavari Drugs Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Godavari Drugs Ltd peers in FMCG
Other FMCG stocks on the NSE & BSE. See the full FMCG sector list.
Related tools & concepts
Value Godavari Drugs Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing